Posts

Post-published clinical data does not always save you (T 0251/25, Empagliflozin)

When do you file for a drug combination invention? (T592/24)

Fordham 33 (Report 4): Life sciences and healthcare innovation

Sufficiency at the priority date: A study protocol is not "the same" as a therapeutic effect invention (T0883/23)

Patentee's own post-published data undermines the credibility of their broad cat antibody patent (T 0709/23)

Event report: C5 Pharma & Biotech Patent Litigation in Europe (Day 1), Plausibility, UPC and antibody IP strategy

UK court reaffirms its stringent plausibility standard in AstraZeneca despite G 2/21

The plausibility of diagnostic inventions: No data, no patent (T 0589/22)